ICD-10-CM Billable Code

C82.02

Follicular lymphoma grade I, intrathoracic lymph nodes

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma that originates from B-lymphocytes, a kind of white blood cell involved in immune response. Grade I indicates that the cancer is low-grade, meaning it tends to grow and spread slowly. When it affects the intrathoracic lymph nodes—those located within the chest cavity—it can present specific challenges and considerations. Understanding this condition involves recognizing its characteristics, causes, symptoms, and available forms of diagnosis and treatment.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B-lymphocyte development Prolonged exposure to certain environmental toxins or chemicals In some cases, a family history of lymphomas or other blood cancers Immune system deficiencies or chronic immune stimulation

Key Symptoms: Swollen lymph nodes in the chest, which may be detected during physical examination or imaging tests Typically painless swelling in the chest area Persistent cough or wheezing if lymph nodes press against airways Shortness of breath or chest discomfort in more advanced cases General symptoms such as fatigue, weight loss, or fevers may be less common in early, low-grade stages

Diagnostic & Treatment

Diagnosis Path: Imaging Procedures: Chest X-rays and computed tomography (CT) scans help visualize enlarged lymph nodes within the chest. Biopsy: A tissue sample from the affected lymph nodes obtained via needle biopsy or surgical excision confirms diagnosis and allows for grading. Histopathological Examination: Under a microscope, pathologists identify the characteristic follicular pattern and low-grade features. Immunophenotyping: Tests such as immunohistochemistry and flow cytometry determine cell markers characteristic of follicular lymphoma. Molecular Studies: Gene rearrangement analyses can support diagnosis and identify specific genetic markers.

Treatment Protocols: Active Surveillance: Monitoring without immediate treatment, especially if asymptomatic and localized, is often recommended due to slow progression. Radiation Therapy: Targeted radiation can be effective for localized lymphadenopathy, controlling growth, and alleviating symptoms. Chemotherapy: Used less frequently in low-grade, localized cases but may be applied in specific circumstances. Immunotherapy: Agents like rituximab, which target B-cell markers, can be employed to improve outcomes. Combination Therapy: Sometimes, a combination of treatments is selected based on disease progression or patient preference.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.02 a billable ICD-10 code?
Yes, C82.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.02?
Clinical documentation must specify the nature of Follicular lymphoma grade I, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

follicular nodes lymphoma intrathoracic lymph